首页 > 最新文献

Annals of surgery最新文献

英文 中文
Patient-Reported Preoperative Depression as a Predictor of Psychosocial Outcomes After Gender-Affirming Facial Feminization Surgery. 患者报告的术前抑郁是性别确认面部女性化手术后心理社会结果的预测因素。
IF 6.4 1区 医学 Q1 SURGERY Pub Date : 2026-03-01 Epub Date: 2024-08-13 DOI: 10.1097/SLA.0000000000006489
Jeremiah M Taylor, Nghiem H Nguyen, Kelly X Huang, Miles J Pfaff, Kavitha Ranganathan, Rebecca C Rada, Mark S Litwin, Marco A Hidalgo, Justine C Lee

Objective: To understand psychosocial functioning before and after gender-affirming facial feminization surgery (FFS) as well as identify predictors of postoperative psychosocial functioning.

Background: Few investigations have rigorously explored the impact of gender-affirming FFS on psychosocial functioning in transgender and gender non-binary (TGNB) individuals. This knowledge gap hinders the identification of methods to optimize mental health quality-of-life outcomes after FFS and carries repercussions for access to care.

Methods: Adult TGNB participants awaiting gender-affirming FFS were prospectively enrolled and administered Patient-Reported Outcomes Measurement Information System (PROMIS) instruments assessing anxiety, anger, depression, global mental and physical health, positive affect, emotional support, social isolation, companionship, and meaning and purpose before and 3-6 months after FFS. Paired t tests compared preoperative and postoperative scores. Multivariable linear models identified predictors of postoperative psychosocial outcomes.

Results: Among the domains, psychosocial scores improved for anxiety, depression, global mental health, social isolation, and positive affect after FFS. When accounting for potential variables contributing to postoperative psychosocial scores, including other gender-affirming surgeries, hormone therapy duration, and private versus public insurance type, we found that preoperative depression scores independently predicted the variance in all other postoperative scores with global mental health (β=-0.52, 95% CI: -0.58 to -0.31 P <0.001), anxiety (β=0.40, 95% CI: 0.21-0.51, P <0.001), and meaning and purpose (β=-0.52, 95% CI: -0.78 to -0.42 P <0.001) as the strongest models.

Conclusions: This study suggests that gender-affirming FFS improves psychosocial functioning; however, such improvements are highly influenced by the baseline psychological functioning of each individual. These findings indicate that preoperative psychological functioning may be a potential avenue for improving outcomes after FFS via perioperative psychological interventions.

目的了解确认性别的面部女性化手术(FFS)前后的社会心理功能,并确定术后社会心理功能的预测因素:很少有研究对变性人和性别非二元性(TGNB)人的性别确认面部女性化手术对社会心理功能的影响进行过严格的探讨。这一知识空白阻碍了确定优化FFS后心理健康生活质量结果的方法,并对获得护理产生影响:方法:前瞻性地招募了等待确认性别的全职家庭护理的成年 TGNB 参与者,并在全职家庭护理前和护理后 3-6 个月使用了患者报告结果测量信息系统(PROMIS)工具,以评估焦虑、愤怒、抑郁、整体身心健康、积极情绪、情感支持、社会隔离、陪伴以及意义和目的。通过配对 t 检验比较了术前和术后的得分。多变量线性模型确定了术后社会心理结果的预测因素:结果:在各领域中,FFS 术后焦虑、抑郁、整体心理健康、社会隔离和积极情绪的社会心理得分均有所提高。当考虑到导致术后社会心理评分的潜在变量(包括其他性别确认手术、激素治疗持续时间以及私人保险与公共保险类型)时,我们发现术前抑郁评分可独立预测术后所有其他评分的差异,并可预测总体心理健康评分(β=-0.52,95%CI -0.58-0.31 PC结论:该研究表明,性别确认手术可改善术后社会心理评分:本研究表明,确认性别的全鼻切除术可改善社会心理功能;然而,这种改善在很大程度上受到每个人的基线心理功能的影响。这些研究结果表明,术前心理功能可能是通过围手术期心理干预改善全麻术后预后的潜在途径。
{"title":"Patient-Reported Preoperative Depression as a Predictor of Psychosocial Outcomes After Gender-Affirming Facial Feminization Surgery.","authors":"Jeremiah M Taylor, Nghiem H Nguyen, Kelly X Huang, Miles J Pfaff, Kavitha Ranganathan, Rebecca C Rada, Mark S Litwin, Marco A Hidalgo, Justine C Lee","doi":"10.1097/SLA.0000000000006489","DOIUrl":"10.1097/SLA.0000000000006489","url":null,"abstract":"<p><strong>Objective: </strong>To understand psychosocial functioning before and after gender-affirming facial feminization surgery (FFS) as well as identify predictors of postoperative psychosocial functioning.</p><p><strong>Background: </strong>Few investigations have rigorously explored the impact of gender-affirming FFS on psychosocial functioning in transgender and gender non-binary (TGNB) individuals. This knowledge gap hinders the identification of methods to optimize mental health quality-of-life outcomes after FFS and carries repercussions for access to care.</p><p><strong>Methods: </strong>Adult TGNB participants awaiting gender-affirming FFS were prospectively enrolled and administered Patient-Reported Outcomes Measurement Information System (PROMIS) instruments assessing anxiety, anger, depression, global mental and physical health, positive affect, emotional support, social isolation, companionship, and meaning and purpose before and 3-6 months after FFS. Paired t tests compared preoperative and postoperative scores. Multivariable linear models identified predictors of postoperative psychosocial outcomes.</p><p><strong>Results: </strong>Among the domains, psychosocial scores improved for anxiety, depression, global mental health, social isolation, and positive affect after FFS. When accounting for potential variables contributing to postoperative psychosocial scores, including other gender-affirming surgeries, hormone therapy duration, and private versus public insurance type, we found that preoperative depression scores independently predicted the variance in all other postoperative scores with global mental health (β=-0.52, 95% CI: -0.58 to -0.31 P <0.001), anxiety (β=0.40, 95% CI: 0.21-0.51, P <0.001), and meaning and purpose (β=-0.52, 95% CI: -0.78 to -0.42 P <0.001) as the strongest models.</p><p><strong>Conclusions: </strong>This study suggests that gender-affirming FFS improves psychosocial functioning; however, such improvements are highly influenced by the baseline psychological functioning of each individual. These findings indicate that preoperative psychological functioning may be a potential avenue for improving outcomes after FFS via perioperative psychological interventions.</p>","PeriodicalId":8017,"journal":{"name":"Annals of surgery","volume":" ","pages":"528-534"},"PeriodicalIF":6.4,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141974940","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Postdischarge Outcomes and Health Care Utilization Among Hispanic/Latinx Injury Survivors: English-language Proficiency Matters. 西班牙裔/拉美裔受伤幸存者出院后的结果和医疗保健使用情况:英语语言能力很重要。
IF 6.4 1区 医学 Q1 SURGERY Pub Date : 2026-03-01 Epub Date: 2024-08-23 DOI: 10.1097/SLA.0000000000006512
Madeline Valverde, Saba Ilkhani, Nathaniel Pinkes, Leah Froehle, Gezzer Ortega, John O Hwabejire, Sabrina E Sanchez, Adil H Haider, Ali Salim, Geoffrey A Anderson, Juan P Herrera-Escobar

Objective: We sought to compare postdischarge outcomes and health care utilization between English-speaking non-Hispanic White (NHW), English-speaking Hispanic/Latinx (ESHL), and Spanish-speaking Hispanic/Latinx (SSHL) survivors of traumatic injury.

Background: While there is evidence of racial and ethnic disparities in health care utilization and postdischarge outcomes after injury, the role of English-language proficiency in these disparities remains unclear.

Methods: Moderate to severely injured adults from 3 level-1 trauma centers completed an interview in English or Spanish between 6 and 12 months postinjury to assess physical health-related quality-of-life (SF-12-PCS), return to work, and postdischarge health care utilization. The language used in the interview was used as a proxy for English-language proficiency, and participants were categorized as either NHW (reference), ESHL, or SSHL. Multivariable regression models estimated independent associations between language and race/ethnicity with SF-12-PCS, return to work, and postdischarge health care utilization outcomes.

Results: A total of 3304 injury survivors were followed: 2977 (90%) NHW, 203 (6%) ESHL, and 124 (4%) SSHL. In adjusted analyses, no significant differences were observed between ESHL and NHW injury survivors for any outcomes at 6 to 12 months postinjury. However, SSHL injury survivors exhibited a lower mean SF-12-PCS (41.6 vs. 38.5), -3.07 (95% CI=-5.47, -0.66; P =0.012), decreased odds of returning to work [odds ratio (OR)=0.47; CI=0.27-0.81; P =0.007], and were less likely to engage in non-injury-related outpatient visits, such as primary care visits (OR=0.45; 95% CI=0.28-0.73; P =0.001), compared with NHW patients.

Conclusion: Hispanic/Latinx injury survivors have worse postdischarge outcomes and lower non-injury-related health care utilization than NHW if they have limited English-language proficiency. Addressing LEP-related barriers to care could help mitigate outcome and health care utilization disparities among Hispanic/Latinx injury survivors.

目的:我们试图比较讲英语的非西班牙裔白人(NHW)、讲英语的西班牙裔/拉美裔(ESHL)和讲西班牙语的西班牙裔/拉美裔(SSHL)创伤幸存者出院后的治疗效果和医疗保健利用率:背景:有证据表明,在受伤后的医疗保健利用率和出院后的治疗效果方面存在种族和民族差异,但英语语言能力在这些差异中的作用仍不清楚:方法:来自三个一级创伤中心的中度至重度伤员在伤后 6-12 个月之间用英语或西班牙语完成了一次访谈,以评估与身体健康相关的生活质量(SF-12-PCS)、重返工作岗位和出院后医疗保健利用率。访谈中使用的语言被用作英语水平的代表,参与者被分为 NHW(参考)、ESHL 或 SSHL。多变量回归模型估计了语言和种族/人种与 SF-12-PCS、重返工作岗位和出院后医疗保健利用率之间的独立关联:对 3,304 名受伤幸存者进行了跟踪调查:结果:对 3,304 名受伤幸存者进行了跟踪调查:2,977 人(90%)为 NHW,203 人(6%)为 ESHL,124 人(4%)为 SSHL。在调整后的分析中,ESHL 和 NHW 受伤幸存者在受伤后 6-12 个月的任何结果方面均未发现明显差异。然而,与 NHW 患者相比,SSHL 受伤幸存者的 SF-12-PCS 平均值较低(41.6 vs. 38.5),为-3.07 (95% CI=-5.47, -0.66; P=0.012),重返工作岗位的几率较低(OR=0.47; CI=0.27 to 0.81; P=0.007),并且不太可能进行与受伤无关的门诊就诊,如初级保健就诊(OR=0.45; 95% CI 0.28, 0.73; P=0.001):结论:如果西班牙裔/拉丁裔受伤幸存者的英语水平有限,他们出院后的治疗效果会比非白血病患者差,与受伤无关的医疗服务利用率也会比白血病患者低。解决与 LEP 相关的护理障碍有助于减轻拉美裔/拉丁裔受伤幸存者在治疗效果和医疗利用率方面的差异。
{"title":"Postdischarge Outcomes and Health Care Utilization Among Hispanic/Latinx Injury Survivors: English-language Proficiency Matters.","authors":"Madeline Valverde, Saba Ilkhani, Nathaniel Pinkes, Leah Froehle, Gezzer Ortega, John O Hwabejire, Sabrina E Sanchez, Adil H Haider, Ali Salim, Geoffrey A Anderson, Juan P Herrera-Escobar","doi":"10.1097/SLA.0000000000006512","DOIUrl":"10.1097/SLA.0000000000006512","url":null,"abstract":"<p><strong>Objective: </strong>We sought to compare postdischarge outcomes and health care utilization between English-speaking non-Hispanic White (NHW), English-speaking Hispanic/Latinx (ESHL), and Spanish-speaking Hispanic/Latinx (SSHL) survivors of traumatic injury.</p><p><strong>Background: </strong>While there is evidence of racial and ethnic disparities in health care utilization and postdischarge outcomes after injury, the role of English-language proficiency in these disparities remains unclear.</p><p><strong>Methods: </strong>Moderate to severely injured adults from 3 level-1 trauma centers completed an interview in English or Spanish between 6 and 12 months postinjury to assess physical health-related quality-of-life (SF-12-PCS), return to work, and postdischarge health care utilization. The language used in the interview was used as a proxy for English-language proficiency, and participants were categorized as either NHW (reference), ESHL, or SSHL. Multivariable regression models estimated independent associations between language and race/ethnicity with SF-12-PCS, return to work, and postdischarge health care utilization outcomes.</p><p><strong>Results: </strong>A total of 3304 injury survivors were followed: 2977 (90%) NHW, 203 (6%) ESHL, and 124 (4%) SSHL. In adjusted analyses, no significant differences were observed between ESHL and NHW injury survivors for any outcomes at 6 to 12 months postinjury. However, SSHL injury survivors exhibited a lower mean SF-12-PCS (41.6 vs. 38.5), -3.07 (95% CI=-5.47, -0.66; P =0.012), decreased odds of returning to work [odds ratio (OR)=0.47; CI=0.27-0.81; P =0.007], and were less likely to engage in non-injury-related outpatient visits, such as primary care visits (OR=0.45; 95% CI=0.28-0.73; P =0.001), compared with NHW patients.</p><p><strong>Conclusion: </strong>Hispanic/Latinx injury survivors have worse postdischarge outcomes and lower non-injury-related health care utilization than NHW if they have limited English-language proficiency. Addressing LEP-related barriers to care could help mitigate outcome and health care utilization disparities among Hispanic/Latinx injury survivors.</p>","PeriodicalId":8017,"journal":{"name":"Annals of surgery","volume":" ","pages":"428-434"},"PeriodicalIF":6.4,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142035038","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Canagliflozin Mitigates Acute Kidney Injury Secondary to Resuscitative Endovascular Balloon Occlusion of the Aorta in a Porcine Model of Hemorrhagic Shock. 在猪失血性休克模型中,卡格列净可减轻因血管内球囊闭塞主动脉导致的急性肾损伤。
IF 6.4 1区 医学 Q1 SURGERY Pub Date : 2026-03-01 Epub Date: 2024-08-23 DOI: 10.1097/SLA.0000000000006501
Simon Tallowin, Biebele Abel, Brinda Mysore, John Mares, Joseph A Anderson, Brandon W Propper, Ian J Stewart, David M Burmeister

Objective: To investigate the potential of acute canagliflozin administration to mitigate acute kidney injury (AKI) and attenuate deleterious pro-inflammatory cytokine release in a clinically relevant swine model of severe renal ischemia reperfusion injury (IRI) induced by hemorrhage and aortic occlusion.

Background: Long-term canagliflozin use attenuates renal function decline and reduces AKI in diabetes mellitus and heart failure patients. While several reports indicate prophylactic SGLT2 inhibition prevents AKI in IRI, the efficacy of acute administration on IRI and inflammation is not known.

Methods: Female swine (n = 16) underwent controlled hemorrhage of 25% blood volume, followed by 90 min of aortic occlusion at the level of the renal ostia (through resuscitative endovascular balloon occlusion of the aorta). A single 300 mg dose of oral canagliflozin or vehicle (saline) was delivered 5 mins into aortic occlusion. Hemodynamic monitoring, markers of renal function (serum creatinine, blood urea nitrogen, proteinuria, and urinary neutrophil gelatinase-associated lipocalin), and serum cytokine concentrations [including interleukins (ILs): IL-1RA, IL-6, IL-8, IL-10, IL-18, and tumor necrosis factor-alpha] were analyzed after IRI, and during a 6-hour critical care phase.

Results: Compared with controls, animals receiving canagliflozin had less severe AKI, improved creatinine clearance, reduced proteinuria, and significantly lower tubular damage as evidenced by histopathology and urinary neutrophil gelatinase-associated lipocalin (NGAL). Furthermore, the pro-inflammatory cytokine IL-6 was markedly attenuated without reduction in anti-inflammatory cytokines (IL-1RA and IL-10).

Conclusions: A single dose of canagliflozin administered shortly into ischemic insult mitigates AKI and attenuates harmful pro-inflammatory cytokine release after controlled hemorrhage in a swine model. These findings suggest a potential novel therapeutic role for canagliflozin in mitigating the effects of renal IRI worthy of further investigation.

目的我们研究了在大出血和主动脉闭塞诱发的严重肾缺血再灌注损伤(IRI)的临床相关猪模型中,急性服用卡格列净(canagliflozin)缓解急性肾损伤(AKI)和减少有害促炎细胞因子释放的潜力:背景:长期服用卡格列净(canagliflozin)可减轻糖尿病和心力衰竭患者的肾功能衰退并减少AKI。虽然一些报告显示预防性 SGLT2 抑制可预防 IRI 中的 AKI,但急性用药对 IRI 和炎症的疗效尚不清楚:方法:雌性猪(n=16)接受 25% 血容量的控制性出血,然后在肾动脉口处进行 90 分钟的主动脉闭塞(通过复苏性血管内球囊闭塞主动脉)。主动脉闭塞5分钟后,口服单剂量300毫克的卡格列净或载体(生理盐水)。血流动力学监测、肾功能指标(血清肌酐、血尿素氮、蛋白尿和尿中性粒细胞明胶酶相关脂褐质)和血清细胞因子浓度(包括白细胞介素:IL-1RA、IL-6、IL-8、IL-10、IL-18和肿瘤坏死因子α)在IRI后和6小时重症监护阶段进行了分析:结果:与对照组相比,接受卡格列净治疗的动物AKI程度较轻,肌酐清除率提高,蛋白尿减少,组织病理学和尿NGAL显示肾小管损伤明显减轻。此外,促炎细胞因子IL-6明显减少,而抗炎细胞因子(IL-1RA和IL-10)却没有减少:结论:在缺血损伤后不久给予单剂量卡格列净可减轻 AKI,并减少创伤或手术后有害的促炎细胞因子释放。这些研究结果表明,卡格列净在减轻肾脏IRI影响方面具有潜在的新型治疗作用,值得进一步研究。
{"title":"Canagliflozin Mitigates Acute Kidney Injury Secondary to Resuscitative Endovascular Balloon Occlusion of the Aorta in a Porcine Model of Hemorrhagic Shock.","authors":"Simon Tallowin, Biebele Abel, Brinda Mysore, John Mares, Joseph A Anderson, Brandon W Propper, Ian J Stewart, David M Burmeister","doi":"10.1097/SLA.0000000000006501","DOIUrl":"10.1097/SLA.0000000000006501","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the potential of acute canagliflozin administration to mitigate acute kidney injury (AKI) and attenuate deleterious pro-inflammatory cytokine release in a clinically relevant swine model of severe renal ischemia reperfusion injury (IRI) induced by hemorrhage and aortic occlusion.</p><p><strong>Background: </strong>Long-term canagliflozin use attenuates renal function decline and reduces AKI in diabetes mellitus and heart failure patients. While several reports indicate prophylactic SGLT2 inhibition prevents AKI in IRI, the efficacy of acute administration on IRI and inflammation is not known.</p><p><strong>Methods: </strong>Female swine (n = 16) underwent controlled hemorrhage of 25% blood volume, followed by 90 min of aortic occlusion at the level of the renal ostia (through resuscitative endovascular balloon occlusion of the aorta). A single 300 mg dose of oral canagliflozin or vehicle (saline) was delivered 5 mins into aortic occlusion. Hemodynamic monitoring, markers of renal function (serum creatinine, blood urea nitrogen, proteinuria, and urinary neutrophil gelatinase-associated lipocalin), and serum cytokine concentrations [including interleukins (ILs): IL-1RA, IL-6, IL-8, IL-10, IL-18, and tumor necrosis factor-alpha] were analyzed after IRI, and during a 6-hour critical care phase.</p><p><strong>Results: </strong>Compared with controls, animals receiving canagliflozin had less severe AKI, improved creatinine clearance, reduced proteinuria, and significantly lower tubular damage as evidenced by histopathology and urinary neutrophil gelatinase-associated lipocalin (NGAL). Furthermore, the pro-inflammatory cytokine IL-6 was markedly attenuated without reduction in anti-inflammatory cytokines (IL-1RA and IL-10).</p><p><strong>Conclusions: </strong>A single dose of canagliflozin administered shortly into ischemic insult mitigates AKI and attenuates harmful pro-inflammatory cytokine release after controlled hemorrhage in a swine model. These findings suggest a potential novel therapeutic role for canagliflozin in mitigating the effects of renal IRI worthy of further investigation.</p>","PeriodicalId":8017,"journal":{"name":"Annals of surgery","volume":" ","pages":"519-527"},"PeriodicalIF":6.4,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12893166/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142034967","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Community Privilege and Unplanned Surgery for Access-sensitive Surgical Conditions. 社区特权和对就医敏感的非计划手术。
IF 6.4 1区 医学 Q1 SURGERY Pub Date : 2026-03-01 Epub Date: 2024-08-23 DOI: 10.1097/SLA.0000000000006511
Muhammad Musaab Munir, Selamawit Woldesenbet, Timothy M Pawlik

Objective: To define the association of privilege on rates of unplanned surgery and perioperative outcomes for access-sensitive surgical conditions.

Background: Social determinants of health (SDOH) are critical in influencing timely access to health care. Privilege represents a right, benefit, advantage, or opportunity that positively influences all SDOH.

Methods: The California Department of Health Care Access and Information database identified patients who underwent abdominal aortic aneurysm repair, ventral hernia repair, or colectomy for colon cancer between 2017 and 2020 and was merged using ZIP codes with the Index of Concentration of Extremes, a validated measure of racial and economic privilege obtained from the American Community Survey. Clustered multivariable regression was performed to assess the association between privilege and outcomes.

Results: Among 185,316 patients who underwent a surgical procedure for one of 3 access-sensitive surgical conditions, roughly 1 in 5 individuals resided in areas with the highest (Q5; n = 37,308; 20.1%) or lowest (Q1; n = 36,352, 19.6%) privilege. Nearly one-half of the surgeries were unplanned (n = 88,814, 46.9%), and colectomy for colon cancer was the most performed emergent procedure. Patients residing in the lowest privileged areas had higher rates of unplanned surgery compared with those residing in the highest privilege [Q1; 55.4% vs 39.4%; referent: Q5; adjusted odds ratio (OR), 1.23, 95% CI: 1.16-1.31; P < 0.001]. For each access-sensitive surgical condition, patients in the least privileged areas were more likely to experience higher rates of inpatient mortality (Q1; 3.1% vs 2.1%; referent: Q5; adjusted OR: 1.41, 95% CI: 1.24-1.60; P < 0.001), perioperative complications (Q1; 30.4% vs Q5; 23.8%; referent: Q5; adjusted OR: 1.24, 95% CI: 1.18-1.31; P < 0.001) and extended hospital stays (Q1; 26.3% vs 20.1%; referent: Q5; adjusted OR: 1.16, 95% CI: 1.09-1.22; P < 0.001).

Conclusions: Privilege was associated with unplanned surgery and adverse clinical outcomes. These data highlight the role of privilege as a key SDOH that influences patient access to and quality of surgical care.

目的:我们试图确定特权与对入路敏感的手术条件的非计划手术率和围术期结果的关系:我们试图确定特权与非计划手术率以及对就医敏感的手术条件的围手术期结果之间的关系:背景:健康的社会决定因素(SDOH)是影响及时获得医疗服务的关键因素。特权代表着一种权利、福利、优势或机会,对所有 SDOH 都有积极影响:加利福尼亚州医疗保健获取与信息部(HCAI)数据库确定了在 2017 年至 2020 年期间接受腹主动脉瘤修补术、腹股沟疝修补术或结肠癌结肠切除术的患者,并使用邮政编码与极端集中指数进行了合并,极端集中指数是从美国社区调查中获得的种族和经济特权的有效衡量标准。研究人员进行了聚类多元回归,以评估特权与结果之间的关联:在 185,316 名因三种手术条件之一而接受手术治疗的患者中,大约五分之一的人居住在特权最高(Q5;n=37,308;20.1%)或最低(Q1;n=36,352,19.6%)的地区。近二分之一的手术是计划外的(n=88,814,46.9%),结肠癌结肠切除术是最常见的急诊手术。与居住在特权最高地区的患者相比,居住在特权最低地区的患者的计划外手术率更高(Q1;55.4% vs. 39.4%;参照:Q5;调整后的几率比[educed odds ratio]):调整后的赔率[OR]为1.23,95%CI为1.16-1.31;结论及相关性:特权与非计划手术率和不良临床结果有关。这表明特权是影响患者获得手术治疗和手术治疗质量的关键性 SDOH。
{"title":"Community Privilege and Unplanned Surgery for Access-sensitive Surgical Conditions.","authors":"Muhammad Musaab Munir, Selamawit Woldesenbet, Timothy M Pawlik","doi":"10.1097/SLA.0000000000006511","DOIUrl":"10.1097/SLA.0000000000006511","url":null,"abstract":"<p><strong>Objective: </strong>To define the association of privilege on rates of unplanned surgery and perioperative outcomes for access-sensitive surgical conditions.</p><p><strong>Background: </strong>Social determinants of health (SDOH) are critical in influencing timely access to health care. Privilege represents a right, benefit, advantage, or opportunity that positively influences all SDOH.</p><p><strong>Methods: </strong>The California Department of Health Care Access and Information database identified patients who underwent abdominal aortic aneurysm repair, ventral hernia repair, or colectomy for colon cancer between 2017 and 2020 and was merged using ZIP codes with the Index of Concentration of Extremes, a validated measure of racial and economic privilege obtained from the American Community Survey. Clustered multivariable regression was performed to assess the association between privilege and outcomes.</p><p><strong>Results: </strong>Among 185,316 patients who underwent a surgical procedure for one of 3 access-sensitive surgical conditions, roughly 1 in 5 individuals resided in areas with the highest (Q5; n = 37,308; 20.1%) or lowest (Q1; n = 36,352, 19.6%) privilege. Nearly one-half of the surgeries were unplanned (n = 88,814, 46.9%), and colectomy for colon cancer was the most performed emergent procedure. Patients residing in the lowest privileged areas had higher rates of unplanned surgery compared with those residing in the highest privilege [Q1; 55.4% vs 39.4%; referent: Q5; adjusted odds ratio (OR), 1.23, 95% CI: 1.16-1.31; P < 0.001]. For each access-sensitive surgical condition, patients in the least privileged areas were more likely to experience higher rates of inpatient mortality (Q1; 3.1% vs 2.1%; referent: Q5; adjusted OR: 1.41, 95% CI: 1.24-1.60; P < 0.001), perioperative complications (Q1; 30.4% vs Q5; 23.8%; referent: Q5; adjusted OR: 1.24, 95% CI: 1.18-1.31; P < 0.001) and extended hospital stays (Q1; 26.3% vs 20.1%; referent: Q5; adjusted OR: 1.16, 95% CI: 1.09-1.22; P < 0.001).</p><p><strong>Conclusions: </strong>Privilege was associated with unplanned surgery and adverse clinical outcomes. These data highlight the role of privilege as a key SDOH that influences patient access to and quality of surgical care.</p>","PeriodicalId":8017,"journal":{"name":"Annals of surgery","volume":" ","pages":"451-458"},"PeriodicalIF":6.4,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142034968","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A New Gold Standard? Impact of Broad-spectrum Penicillin-based Antibiotic Prophylaxis on Outcome After Pancreatoduodenectomy: Results of a Systematic Review and Meta-analysis (PROSPERO CRD42024559197). 新的金本位制?广谱青霉素类抗生素预防对胰十二指肠切除术后预后的影响——系统评价和荟萃分析的结果(PROSPERO CRD42024559197)。
IF 6.4 1区 医学 Q1 SURGERY Pub Date : 2026-03-01 Epub Date: 2025-03-21 DOI: 10.1097/SLA.0000000000006703
Julian C Harnoss, Darius Halm, Sophie Weber, Benedict Kinny-Köster, Max Heckler, Rosa Klotz, Eva Kalkum, Jonathan M Harnoss, Julian Musa, Pascal Probst, Christoph W Michalski, Martin Loos, Thomas Hank

Objective: This review evaluated whether broad-spectrum penicillin-based antibiotic prophylaxis (BS-AB) such as piperacillin-tazobactam might lead to better outcomes in pancreatoduodenectomy compared with standard care antibiotics, mainly cephalosporins (CE-AB).

Background: Pancreatoduodenectomy is commonly associated with high postoperative infectious complications, contributing to increased morbidity, mortality, and health care costs.

Methods: A systemic literature search (PubMed, EMBASE, Cochrane Library, and Web of Science) was conducted to identify suitable RCTs and non-RCTs. After inclusion, the data were analyzed using a random-effects model with the Mantel-Haenszel model or inverse variance to calculate odds ratio (OR) or mean difference (MD) with 95% confidence intervals (CI).

Results: One RCT and 11 non-RCTs were included with 12,469 patients (35.3% BS-AB, 64.7% CE-AB). Surgical site infections (SSI) were significantly lower after BS-AB when compared with CE-AB, [OR 0.53; CI (0.32 to 0.86); P =0.01; I2 =79%] as well as the occurrence of postoperative pancreatic fistula (POPF) [OR 0.62; CI (0.47 to 0.81); P <0.01; I2 =0%], days of hospitalization [MD -2.02; CI (-4.08 to 0.03); P =0.05; I2 =98%] and mortality [OR 0.56; CI (0.34 to 0.95); P =0.03; I2 =0%]. Subgroup analyses of patients with preoperative biliary drainage demonstrated an even higher effect of BS-AB in reducing SSI [OR 0.45, CI (0.45 to 0.67); P =0.01; I2 =78%], POPF [OR 0.52; CI (0.36 to 0.75); P <0.01; I2 =0%] and mortality [OR 0.34; CI (0.15 to 0.76); P <0.01; I2 =0%].

Conclusion: BS-AB significantly reduces the risk of infectious complications and surgical outcomes in pancreatoduodenectomy compared with CE-AB, particularly in patients with preoperative biliary drainage. These findings support the use of BS-AB as a new gold standard for patients undergoing pancreatoduodenectomy.

目的:本综述评估了哌拉西林-他唑巴坦等广谱青霉素类抗生素预防性治疗(BS-AB)与标准治疗抗生素(主要是头孢菌素类)(CE-AB)相比,是否能为胰腺十二指肠切除术带来更好的治疗效果:背景:胰十二指肠切除术通常伴有较高的术后感染并发症,导致发病率、死亡率和医疗成本增加:方法:对文献进行系统检索(PubMed、EMBASE、Cochrane Library 和 Web of Science),以确定合适的 RCT 和非 RCT。纳入后,使用随机效应模型与曼特尔-海恩泽尔模型或反方差对数据进行分析,计算出几率比(OR)或平均差(MD)以及 95% 的置信区间(CI):结果:共纳入 1 项 RCT 和 11 项非 RCT,12469 名患者(35.3% 为 BS-AB,64.7% 为 CE-AB)。与CE-AB相比,BS-AB术后手术部位感染(SSI)明显降低(OR 0.53;CI [0.32-0.86];P =0.01;I 2 =79%),术后胰瘘(POPF)的发生率也明显降低(OR 0.62;CI [0.47-0.81];P 结论:BS-AB可显著降低术后胰瘘的发生率:与 CE-AB 相比,BS-AB 能明显降低胰十二指肠切除术中感染并发症的风险和手术效果,尤其是术前有胆道引流的患者。这些研究结果支持将 BS-AB 作为胰十二指肠切除术患者的新金标准。
{"title":"A New Gold Standard? Impact of Broad-spectrum Penicillin-based Antibiotic Prophylaxis on Outcome After Pancreatoduodenectomy: Results of a Systematic Review and Meta-analysis (PROSPERO CRD42024559197).","authors":"Julian C Harnoss, Darius Halm, Sophie Weber, Benedict Kinny-Köster, Max Heckler, Rosa Klotz, Eva Kalkum, Jonathan M Harnoss, Julian Musa, Pascal Probst, Christoph W Michalski, Martin Loos, Thomas Hank","doi":"10.1097/SLA.0000000000006703","DOIUrl":"10.1097/SLA.0000000000006703","url":null,"abstract":"<p><strong>Objective: </strong>This review evaluated whether broad-spectrum penicillin-based antibiotic prophylaxis (BS-AB) such as piperacillin-tazobactam might lead to better outcomes in pancreatoduodenectomy compared with standard care antibiotics, mainly cephalosporins (CE-AB).</p><p><strong>Background: </strong>Pancreatoduodenectomy is commonly associated with high postoperative infectious complications, contributing to increased morbidity, mortality, and health care costs.</p><p><strong>Methods: </strong>A systemic literature search (PubMed, EMBASE, Cochrane Library, and Web of Science) was conducted to identify suitable RCTs and non-RCTs. After inclusion, the data were analyzed using a random-effects model with the Mantel-Haenszel model or inverse variance to calculate odds ratio (OR) or mean difference (MD) with 95% confidence intervals (CI).</p><p><strong>Results: </strong>One RCT and 11 non-RCTs were included with 12,469 patients (35.3% BS-AB, 64.7% CE-AB). Surgical site infections (SSI) were significantly lower after BS-AB when compared with CE-AB, [OR 0.53; CI (0.32 to 0.86); P =0.01; I2 =79%] as well as the occurrence of postoperative pancreatic fistula (POPF) [OR 0.62; CI (0.47 to 0.81); P <0.01; I2 =0%], days of hospitalization [MD -2.02; CI (-4.08 to 0.03); P =0.05; I2 =98%] and mortality [OR 0.56; CI (0.34 to 0.95); P =0.03; I2 =0%]. Subgroup analyses of patients with preoperative biliary drainage demonstrated an even higher effect of BS-AB in reducing SSI [OR 0.45, CI (0.45 to 0.67); P =0.01; I2 =78%], POPF [OR 0.52; CI (0.36 to 0.75); P <0.01; I2 =0%] and mortality [OR 0.34; CI (0.15 to 0.76); P <0.01; I2 =0%].</p><p><strong>Conclusion: </strong>BS-AB significantly reduces the risk of infectious complications and surgical outcomes in pancreatoduodenectomy compared with CE-AB, particularly in patients with preoperative biliary drainage. These findings support the use of BS-AB as a new gold standard for patients undergoing pancreatoduodenectomy.</p>","PeriodicalId":8017,"journal":{"name":"Annals of surgery","volume":" ","pages":"418-427"},"PeriodicalIF":6.4,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12893182/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143668787","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluating the Impact of Robotic Ileal Pouch-anal Anastomosis: A Case-matched Analysis From a High-volume Center. 评估机器人 IPAA 的影响:来自高流量中心的病例匹配分析。
IF 6.4 1区 医学 Q1 SURGERY Pub Date : 2026-03-01 Epub Date: 2024-09-05 DOI: 10.1097/SLA.0000000000006524
Tommaso Violante, Davide Ferrari, Marco Novelli, Kevin T Behm, William R Perry, Kellie L Mathis, Eric J Dozois, Amit Merchea, Sherief S Shawki, David W Larson

Objective: To compare robotic-assisted proctectomy with ileal pouch-anal anastomosis (R-IPAA) outcomes and laparoscopic proctectomy with IPAA within a specialized robotic surgery center, using matching techniques to minimize potential confounding factors.

Background: Minimally invasive approaches, particularly laparoscopy, have improved outcomes for patients with inflammatory bowel disease and familial adenomatous polyposis undergoing IPAA. Robotic-assisted surgery offers potential technical advantages, but its definitive superiority over laparoscopy in this context remains under debate.

Methods: This retrospective, "Strengthening the Reporting of Observational Studies in Epidemiology"-compliant study analyzed 234 consecutive patients undergoing IPAA (117 robotic and 117 laparoscopic). Data encompassed patient demographics, intraoperative details, and postoperative outcomes. We employed various matching techniques to address potential bias. Primary endpoints focused on 30-day complications, readmissions, and reoperations, with secondary endpoints including hospital stay, blood loss, and stoma closure rates.

Results: R-IPAA demonstrated a lower conversion rate to open surgery ( P = 0.02), a shorter hospital stay ( P = 0.04), and reduced blood loss ( P = 0.0003) compared with laparoscopic proctectomy with IPAA. While overall 30-day morbidity rates were similar ( P = 0.4), matched analyses suggested a trend towards fewer reoperations and 3-month IPAA-associated complications after diverting loop ileostomy closure in the robotic group. However, these differences did not reach statistical significance.

Conclusions: In a high-volume robotic surgery center, R-IPAA reduced the risk of conversion to open surgery while reducing intraoperative blood loss and providing shorter lengths of stay with equivalent perioperative outcomes. Promising trends to reduce 30-day reoperations and surgical complications after diverting loop ileostomy closure were observed after a matching analysis.

目的在一家专业的机器人手术中心内,比较机器人辅助直肠切除术(R-IPAA)和腹腔镜直肠切除术(L-IPAA)的效果,采用匹配技术将潜在的混杂因素降至最低:微创方法,尤其是腹腔镜手术,改善了接受IPAA手术的IBD和FAP患者的治疗效果。机器人辅助手术具有潜在的技术优势,但在这种情况下,机器人辅助手术相对于腹腔镜手术的绝对优势仍有待商榷:这项符合 STROBE 标准的回顾性研究分析了 234 例连续的 IPAA 患者(117 例机器人手术,117 例腹腔镜手术)。数据包括患者的人口统计学特征、术中细节和术后结果。我们采用了各种匹配技术来解决潜在的偏差。主要终点集中在30天并发症、再入院和再手术,次要终点包括住院时间、失血量和造口关闭率:与L-IPAA相比,R-IPAA的开腹手术转换率更低(P=0.02),住院时间更短(P=0.04),失血量更少(P=0.0003)。虽然30天的总体发病率相似(P=0.4),但匹配分析表明,机器人组的再次手术和转流环回肠造口术后3个月的IPAA相关并发症有减少的趋势。然而,这些差异并未达到统计学意义:在一个高容量机器人手术中心,R-IPAA降低了转为开放手术的风险,同时减少了术中失血,缩短了住院时间,围手术期结果相当。在进行匹配分析后发现,DLI闭合术后30天再手术和手术并发症的减少趋势良好。
{"title":"Evaluating the Impact of Robotic Ileal Pouch-anal Anastomosis: A Case-matched Analysis From a High-volume Center.","authors":"Tommaso Violante, Davide Ferrari, Marco Novelli, Kevin T Behm, William R Perry, Kellie L Mathis, Eric J Dozois, Amit Merchea, Sherief S Shawki, David W Larson","doi":"10.1097/SLA.0000000000006524","DOIUrl":"10.1097/SLA.0000000000006524","url":null,"abstract":"<p><strong>Objective: </strong>To compare robotic-assisted proctectomy with ileal pouch-anal anastomosis (R-IPAA) outcomes and laparoscopic proctectomy with IPAA within a specialized robotic surgery center, using matching techniques to minimize potential confounding factors.</p><p><strong>Background: </strong>Minimally invasive approaches, particularly laparoscopy, have improved outcomes for patients with inflammatory bowel disease and familial adenomatous polyposis undergoing IPAA. Robotic-assisted surgery offers potential technical advantages, but its definitive superiority over laparoscopy in this context remains under debate.</p><p><strong>Methods: </strong>This retrospective, \"Strengthening the Reporting of Observational Studies in Epidemiology\"-compliant study analyzed 234 consecutive patients undergoing IPAA (117 robotic and 117 laparoscopic). Data encompassed patient demographics, intraoperative details, and postoperative outcomes. We employed various matching techniques to address potential bias. Primary endpoints focused on 30-day complications, readmissions, and reoperations, with secondary endpoints including hospital stay, blood loss, and stoma closure rates.</p><p><strong>Results: </strong>R-IPAA demonstrated a lower conversion rate to open surgery ( P = 0.02), a shorter hospital stay ( P = 0.04), and reduced blood loss ( P = 0.0003) compared with laparoscopic proctectomy with IPAA. While overall 30-day morbidity rates were similar ( P = 0.4), matched analyses suggested a trend towards fewer reoperations and 3-month IPAA-associated complications after diverting loop ileostomy closure in the robotic group. However, these differences did not reach statistical significance.</p><p><strong>Conclusions: </strong>In a high-volume robotic surgery center, R-IPAA reduced the risk of conversion to open surgery while reducing intraoperative blood loss and providing shorter lengths of stay with equivalent perioperative outcomes. Promising trends to reduce 30-day reoperations and surgical complications after diverting loop ileostomy closure were observed after a matching analysis.</p>","PeriodicalId":8017,"journal":{"name":"Annals of surgery","volume":" ","pages":"513-518"},"PeriodicalIF":6.4,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142131578","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prospective Validation of the Pancreatic Fistula Risk Classification by the International Study Group for Pancreatic Surgery (PARIS Trial). 国际胰腺外科研究小组对胰腺瘘风险分类的前瞻性验证(PARIS 试验)。
IF 6.4 1区 医学 Q1 SURGERY Pub Date : 2026-03-01 Epub Date: 2024-08-08 DOI: 10.1097/SLA.0000000000006481
Fabian Schuh, Berk Yildirim, Rosa Klotz, Frank Pianka, Andrea Boskovic, Alexander Werba, Matthias A Fink, Caroline Wild, Constantin Schwab, Christoph Eckert, Manuel Feisst, André L Mihaljevic, Martin Loos, Markus Büchler, Pascal Probst

Objective: To prospectively validate the recently established International Study Group for Pancreatic Surgery (ISGPS) pancreas classification as a parenchymal risk classification system for pancreatic fistula after pancreatoduodenectomy.

Background: Postoperative pancreatic fistula (POPF) is the major driver for complications after partial pancreatoduodenectomy (PD). Recently, the ISGPS published a pancreas classification containing the parameters of main pancreatic duct diameter and pancreatic texture to help assess the risk of POPF development after PD.

Methods: From January 2020 to July 2021, 271 patients receiving elective PD were included after informed consent. The postoperative course was documented prospectively up to postoperative day 30. Among the pancreas characteristics, the main pancreatic duct and pancreatic texture were assessed intraoperatively at the pancreatic resection margin, and the pancreatic glands were assigned to one of the 4 pancreas classes according to the ISGPS (A-D). The primary endpoint was POPF according to the updated ISGPS definition. Secondary endpoints comprised other post-PD morbidity and mortality.

Results: Of 271 patients, 264 had available data according to the ISGPS pancreas classification. Of those, 78 were assigned to class A (30%), 53 to class B (20%), 50 to class C (19%) and 83 to class D (31%). POPF occurred in 54 of 271 patients (19.9%). The 30-day mortality was 7/271 (2.6%), with 6/7 having developed POPF (86%). POPF rates within the classes A, B, C, and D were 9.0%, 11.3%, 20.0%, and 37.4%, respectively ( P < 0.001). In the univariable regression analysis, only patients in pancreas class D demonstrated a significantly higher risk for POPF when compared with class A (odds ratio: 6.05; 95% CI: 2.6-15.9; P < 0.001). In the multivariable regression model, patients in class D had a significantly higher risk for POPF compared with class A (odds ratio: 3.45; 95% CI: 1.15-11.3; P = 0.032). The model comprised body mass index, surgery duration, microscopic fibrosis, and the ISGPS pancreas classification, demonstrating an area under the curve (AUC) value of ∼0.82 when tested on the PARIS data set.

Conclusions: This prospective trial shows that the ISGPS pancreas classification is valid. Patients in risk class D are prone to POPF independently of other factors. Therefore, all future publications on pancreatic surgery should report the risk class according to the ISGPS pancreas classification to allow for a better comparison of reported cohorts.

目的:本研究的目的是对最近建立的 ISGPS 胰腺分类进行前瞻性验证,将其作为胰十二指肠切除术后胰瘘的实质风险分类系统:术后胰瘘(POPF)是胰十二指肠部分切除术(PD)后并发症的主要原因。最近,国际胰腺外科研究小组(ISGPS)公布了一种胰腺分类方法,其中包含主胰管直径(MPD)和胰腺纹理参数,以帮助评估胰十二指肠切除术后发生胰瘘的风险:2020年1月至2021年7月,在知情同意后纳入了271名接受择期胰十二指肠切除术的患者。前瞻性记录了截至术后第 30 天的术后病程。在胰腺特征中,术中在胰腺切除边缘评估 MPD 和胰腺质地,并根据 ISGPS(A 至 D)将胰腺划分为四个胰腺等级之一。根据最新的 ISGPS 定义,主要终点是 POPF。次要终点包括胰腺癌术后的其他发病率和死亡率:结果:在 271 名患者中,264 人有 ISGPS 胰腺分类的可用数据。其中,78人被归入A级(30%),53人被归入B级(20%),50人被归入C级(19%),83人被归入D级(31%)。271 例患者中有 54 例(19.9%)发生了 POPF。30 天死亡率为 7/271(2.6%),其中 6/7 出现了 POPF(86%)。在 A、B、C 和 D 级中,POPF 的发生率分别为 9.0%、11.3%、20.0% 和 37.4%(PC 结论:这项前瞻性试验表明,ISGPS胰腺分级是有效的。风险等级为 D 的患者易患 POPF,与其他因素无关。因此,今后所有关于胰腺手术的出版物都应根据 ISGPS 胰腺分类报告风险等级,以便更好地比较所报告的队列。
{"title":"Prospective Validation of the Pancreatic Fistula Risk Classification by the International Study Group for Pancreatic Surgery (PARIS Trial).","authors":"Fabian Schuh, Berk Yildirim, Rosa Klotz, Frank Pianka, Andrea Boskovic, Alexander Werba, Matthias A Fink, Caroline Wild, Constantin Schwab, Christoph Eckert, Manuel Feisst, André L Mihaljevic, Martin Loos, Markus Büchler, Pascal Probst","doi":"10.1097/SLA.0000000000006481","DOIUrl":"10.1097/SLA.0000000000006481","url":null,"abstract":"<p><strong>Objective: </strong>To prospectively validate the recently established International Study Group for Pancreatic Surgery (ISGPS) pancreas classification as a parenchymal risk classification system for pancreatic fistula after pancreatoduodenectomy.</p><p><strong>Background: </strong>Postoperative pancreatic fistula (POPF) is the major driver for complications after partial pancreatoduodenectomy (PD). Recently, the ISGPS published a pancreas classification containing the parameters of main pancreatic duct diameter and pancreatic texture to help assess the risk of POPF development after PD.</p><p><strong>Methods: </strong>From January 2020 to July 2021, 271 patients receiving elective PD were included after informed consent. The postoperative course was documented prospectively up to postoperative day 30. Among the pancreas characteristics, the main pancreatic duct and pancreatic texture were assessed intraoperatively at the pancreatic resection margin, and the pancreatic glands were assigned to one of the 4 pancreas classes according to the ISGPS (A-D). The primary endpoint was POPF according to the updated ISGPS definition. Secondary endpoints comprised other post-PD morbidity and mortality.</p><p><strong>Results: </strong>Of 271 patients, 264 had available data according to the ISGPS pancreas classification. Of those, 78 were assigned to class A (30%), 53 to class B (20%), 50 to class C (19%) and 83 to class D (31%). POPF occurred in 54 of 271 patients (19.9%). The 30-day mortality was 7/271 (2.6%), with 6/7 having developed POPF (86%). POPF rates within the classes A, B, C, and D were 9.0%, 11.3%, 20.0%, and 37.4%, respectively ( P < 0.001). In the univariable regression analysis, only patients in pancreas class D demonstrated a significantly higher risk for POPF when compared with class A (odds ratio: 6.05; 95% CI: 2.6-15.9; P < 0.001). In the multivariable regression model, patients in class D had a significantly higher risk for POPF compared with class A (odds ratio: 3.45; 95% CI: 1.15-11.3; P = 0.032). The model comprised body mass index, surgery duration, microscopic fibrosis, and the ISGPS pancreas classification, demonstrating an area under the curve (AUC) value of ∼0.82 when tested on the PARIS data set.</p><p><strong>Conclusions: </strong>This prospective trial shows that the ISGPS pancreas classification is valid. Patients in risk class D are prone to POPF independently of other factors. Therefore, all future publications on pancreatic surgery should report the risk class according to the ISGPS pancreas classification to allow for a better comparison of reported cohorts.</p>","PeriodicalId":8017,"journal":{"name":"Annals of surgery","volume":" ","pages":"495-504"},"PeriodicalIF":6.4,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141900786","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lymph Node Yield Is Associated With Improved Overall Survival and Increased Time to Recurrence in Node-Negative Pancreatic Ductal Adenocarcinoma Following Neoadjuvant Therapy. 淋巴结痊愈率与结节阴性胰腺导管腺癌新辅助治疗后总生存率的提高和复发时间的延长有关。
IF 6.4 1区 医学 Q1 SURGERY Pub Date : 2026-03-01 Epub Date: 2024-07-02 DOI: 10.1097/SLA.0000000000006432
Maximiliano Servin-Rojas, Zhi Ven Fong, Carlos Fernandez-Del Castillo, Gabriella Lionetto, Louisa Bolm, Peter J Fagenholz, Cristina R Ferrone, Dario M Rocha-Castellanos, Keith D Lillemoe, Motaz Qadan

Objective: To determine whether lymph node yield (LNY) is associated with improved overall survival (OS) and time to recurrence (TTR) in patients with node-negative pancreatic ductal adenocarcinoma (PDAC) treated with neoadjuvant therapy (NAT).

Background: LNY has been associated with survival in solid gastrointestinal cancers, including PDAC.

Methods: Patients with pathologic T stage I to III, node-negative (N0), PDAC treated with NAT followed by pancreatoduodenectomy were identified in the Massachusetts General Hospital pancreatectomy database and the National Cancer Database (NCDB). A cutoff point of 22 nodes was identified in the NCDB using the point with the optimal (log-rank test) split. OS and TTR were evaluated using univariate and multivariable analyses.

Results: In the Massachusetts General Hospital cohort, 233 node-negative patients following NAT were included. A LNY ≥ 22 was associated with prolonged median OS (59 vs 25 mo, P <0.001) and prolonged TTR (32 vs 14 mo, P =0.019). On multivariable analysis, LNY was an independent predictor of survival (HR 0.97, 95% CI: 0.95-0.99, P =0.034) per sampled node. In the NCDB, 2029 node-negative patients following NAT were included. A LNY ≥ 22 was associated with prolonged median OS (49 vs 33 mo, P <0.001). On multivariable analysis, LNY was an independent predictor of survival (HR 0.99, 95% CI: 0.98-0.99, P <0.001) per sampled node.

Conclusions: LNY was associated with improved oncologic outcomes in patients treated with NAT followed by pancreatoduodenectomy in two independent data sets. Responsible mechanisms by which LNY impacts the outcomes of node-negative patients following NAT warrant further exploration.

目的背景:淋巴结转移率(LNY)是否与接受新辅助治疗(NAT)的结节阴性胰腺导管腺癌(PDAC)患者总生存率(OS)和复发时间(TTR)的改善有关:背景:淋巴结率与包括PDAC在内的实体胃肠道癌症患者的生存率有关:方法:从马萨诸塞州总医院(MGH)胰腺切除术数据库和美国国家癌症数据库(NCDB)中筛选出病理T I-III期、结节阴性(N0)、接受NAT治疗后进行胰十二指肠切除术的PDAC患者。在 NCDB 中使用最佳(对数秩检验)分割点确定了 22 个结节的分界点。通过单变量和多变量分析评估了总生存率和TTR:在MGH队列中,纳入了233例NAT后结节阴性的患者。淋巴结活检率≥22与中位OS延长有关(59个月对25个月,PC结论:淋巴结活检率与中位OS延长有关:在两个独立的数据集中,淋巴结得率与胰十二指肠切除术后接受 NAT 治疗的患者肿瘤预后的改善有关。淋巴结活检率对胰腺结节阴性患者接受 NAT 治疗后的预后产生影响的机制值得进一步探讨。
{"title":"Lymph Node Yield Is Associated With Improved Overall Survival and Increased Time to Recurrence in Node-Negative Pancreatic Ductal Adenocarcinoma Following Neoadjuvant Therapy.","authors":"Maximiliano Servin-Rojas, Zhi Ven Fong, Carlos Fernandez-Del Castillo, Gabriella Lionetto, Louisa Bolm, Peter J Fagenholz, Cristina R Ferrone, Dario M Rocha-Castellanos, Keith D Lillemoe, Motaz Qadan","doi":"10.1097/SLA.0000000000006432","DOIUrl":"10.1097/SLA.0000000000006432","url":null,"abstract":"<p><strong>Objective: </strong>To determine whether lymph node yield (LNY) is associated with improved overall survival (OS) and time to recurrence (TTR) in patients with node-negative pancreatic ductal adenocarcinoma (PDAC) treated with neoadjuvant therapy (NAT).</p><p><strong>Background: </strong>LNY has been associated with survival in solid gastrointestinal cancers, including PDAC.</p><p><strong>Methods: </strong>Patients with pathologic T stage I to III, node-negative (N0), PDAC treated with NAT followed by pancreatoduodenectomy were identified in the Massachusetts General Hospital pancreatectomy database and the National Cancer Database (NCDB). A cutoff point of 22 nodes was identified in the NCDB using the point with the optimal (log-rank test) split. OS and TTR were evaluated using univariate and multivariable analyses.</p><p><strong>Results: </strong>In the Massachusetts General Hospital cohort, 233 node-negative patients following NAT were included. A LNY ≥ 22 was associated with prolonged median OS (59 vs 25 mo, P <0.001) and prolonged TTR (32 vs 14 mo, P =0.019). On multivariable analysis, LNY was an independent predictor of survival (HR 0.97, 95% CI: 0.95-0.99, P =0.034) per sampled node. In the NCDB, 2029 node-negative patients following NAT were included. A LNY ≥ 22 was associated with prolonged median OS (49 vs 33 mo, P <0.001). On multivariable analysis, LNY was an independent predictor of survival (HR 0.99, 95% CI: 0.98-0.99, P <0.001) per sampled node.</p><p><strong>Conclusions: </strong>LNY was associated with improved oncologic outcomes in patients treated with NAT followed by pancreatoduodenectomy in two independent data sets. Responsible mechanisms by which LNY impacts the outcomes of node-negative patients following NAT warrant further exploration.</p>","PeriodicalId":8017,"journal":{"name":"Annals of surgery","volume":" ","pages":"488-494"},"PeriodicalIF":6.4,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141475763","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Number of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Treatments is Associated With Longer Survival: Analysis of a Large Prospective Cohort of Patients With Unresectable Peritoneal Surface Malignancies. 腹腔内加压气溶胶化疗 (PIPAC) 治疗次数与较长的生存期有关:对腹膜表面不可切除恶性肿瘤患者大型前瞻性队列的分析。
IF 6.4 1区 医学 Q1 SURGERY Pub Date : 2026-03-01 Epub Date: 2024-07-23 DOI: 10.1097/SLA.0000000000006447
Ran Orgad, Naoual Bakrin, Isabelle Bonnefoy, Laurent Villeneuve, Mohamad Alyami, Omar Alhadeedi, Olivier Glehen, Vahan Kepenekian

Objective: To analyze the reasons for stopping pressurized intraperitoneal aerosolized chemotherapy (PIPAC) delivered for unresectable peritoneal surface malignancies (PSMs) and to determine survival in a large patient cohort of an experienced PIPAC center.

Background: PIPAC alone or combined with systemic chemotherapy was developed to palliatively treat unresectable PSM. Safety, tolerance, and promising survival results were already reported, but the reasons for stopping treatment remain unclear, and the influence of the number of PIPAC procedures on prognosis has not been evaluated.

Methods: A retrospective analysis of PIPAC procedures from a prospectively maintained single-institution PSM database was conducted from January 2016 to January 2023.

Results: A total of 346 patients underwent 1200 PIPAC treatments in the defined time period. Two-thirds of the patients completed 3 or more PIPAC procedures, and 2 patients had more than 15 treatment procedures. Reasons for PIPAC cessation were disease progression or complication (56%), reorientation to a potential curative procedure (19%), surgical complications of the procedure (13%), death between procedures (8%), and patient request (3%). PSM origin and receiving 3 or more PIPAC treatments were independently correlated with better survival in the overall population, in the group of ultimately unresectable PSM, and after propensity score weighting.

Conclusions: The main reason for stopping PIPAC treatment in the palliative management of PSM is disease progression. When 3 or more PIPAC procedures can be delivered in combination with systemic chemotherapy, survival is significantly improved. Its use should be validated by prospective studies.

目的分析对不可切除的腹膜表面恶性肿瘤(PSM)停止加压腹腔内雾化化疗(PIPAC)的原因,并确定一家经验丰富的PIPAC中心的大型患者队列的存活率:背景:PIPAC单独或与全身化疗联合用于姑息治疗不可切除的腹膜表面恶性肿瘤。背景:PIPAC 单独或联合全身化疗用于姑息治疗不可切除的 PSM,其安全性、耐受性和可喜的生存结果已被报道,但停止治疗的原因仍不清楚,PIPAC 治疗次数对预后的影响也未被评估:方法:从2016年1月至2023年1月,对前瞻性维护的单一机构PSM数据库中的PIPAC手术进行回顾性分析:结果:在规定时间内,共有346名患者接受了1200次PIPAC治疗。三分之二的患者完成了 3 次或 3 次以上的 PIPAC 治疗,2 名患者完成了 15 次以上的治疗。停止 PIPAC 治疗的原因包括疾病进展或并发症(56%)、重新定位到潜在的治疗程序(19%)、程序的手术并发症(13%)、程序之间的死亡(8%)和患者要求(3%)。PSM起源和接受3次或3次以上PIPAC治疗与总体人群、最终无法切除的PSM人群以及倾向得分加权后的较高生存率独立相关:结论:在PSM姑息治疗中,停止PIPAC治疗的主要原因是疾病进展。如果能在全身化疗的基础上进行 3 次或更多次 PIPAC 治疗,患者的生存率将得到显著提高。其应用应通过前瞻性研究加以验证。
{"title":"Number of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Treatments is Associated With Longer Survival: Analysis of a Large Prospective Cohort of Patients With Unresectable Peritoneal Surface Malignancies.","authors":"Ran Orgad, Naoual Bakrin, Isabelle Bonnefoy, Laurent Villeneuve, Mohamad Alyami, Omar Alhadeedi, Olivier Glehen, Vahan Kepenekian","doi":"10.1097/SLA.0000000000006447","DOIUrl":"10.1097/SLA.0000000000006447","url":null,"abstract":"<p><strong>Objective: </strong>To analyze the reasons for stopping pressurized intraperitoneal aerosolized chemotherapy (PIPAC) delivered for unresectable peritoneal surface malignancies (PSMs) and to determine survival in a large patient cohort of an experienced PIPAC center.</p><p><strong>Background: </strong>PIPAC alone or combined with systemic chemotherapy was developed to palliatively treat unresectable PSM. Safety, tolerance, and promising survival results were already reported, but the reasons for stopping treatment remain unclear, and the influence of the number of PIPAC procedures on prognosis has not been evaluated.</p><p><strong>Methods: </strong>A retrospective analysis of PIPAC procedures from a prospectively maintained single-institution PSM database was conducted from January 2016 to January 2023.</p><p><strong>Results: </strong>A total of 346 patients underwent 1200 PIPAC treatments in the defined time period. Two-thirds of the patients completed 3 or more PIPAC procedures, and 2 patients had more than 15 treatment procedures. Reasons for PIPAC cessation were disease progression or complication (56%), reorientation to a potential curative procedure (19%), surgical complications of the procedure (13%), death between procedures (8%), and patient request (3%). PSM origin and receiving 3 or more PIPAC treatments were independently correlated with better survival in the overall population, in the group of ultimately unresectable PSM, and after propensity score weighting.</p><p><strong>Conclusions: </strong>The main reason for stopping PIPAC treatment in the palliative management of PSM is disease progression. When 3 or more PIPAC procedures can be delivered in combination with systemic chemotherapy, survival is significantly improved. Its use should be validated by prospective studies.</p>","PeriodicalId":8017,"journal":{"name":"Annals of surgery","volume":" ","pages":"505-512"},"PeriodicalIF":6.4,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141747262","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Social Capital and Surgery Access Among Medicare Beneficiaries. 医疗保险受益人的社会资本与手术机会。
IF 6.4 1区 医学 Q1 SURGERY Pub Date : 2026-03-01 Epub Date: 2024-08-13 DOI: 10.1097/SLA.0000000000006482
Hannah E W Myers, Nicholas Kunnath, Andrew M Ibrahim

Objective: To compare the rates of unplanned procedures for access-sensitive surgical conditions among beneficiaries living in census tracts of varying social capital levels.

Background: Access-sensitive surgical conditions are conditions ideally screened for and treated in an elective setting. However, when left untreated, these conditions may result in unplanned (ie, urgent or emergent) surgery. It is possible that social capital-the resources available to individuals through their membership in a social network-may impact the likelihood of a planned procedure occurring.

Methods: Medicare beneficiaries who underwent 1 of 3 access-sensitive procedures (abdominal aortic aneurysm repair, colectomy for cancer, and ventral hernia repair) between 2016 and 2020 were stratified by their census tract level of social capital, the exposure variable. Outcomes included rate of unplanned surgery, readmission, 30-day mortality, and complications which were risk-adjusted with a logistic regression model that accounted for patient age, sex, race, comorbidities, and area deprivation.

Results: A total of 975,048 beneficiaries were included [mean (SD) patient age, 76 (7.6) years; 443,190 were male (45.45%)]. Compared with patients from census tracts in the highest overall social capital decile, those from census tracts with the least social capital were, on average, more likely to undergo unplanned surgery [40.67% vs 35.28%, odds ratio (OR)=1.26 P <0.001]. In addition, beneficiaries in these communities were also more likely to experience postoperative complications (24.99% vs 22.90%, OR=1.12 P <0.001), but there was no significant difference in rates of readmission or mortality. When evaluating only elective procedures, the differences between the lowest and highest social capital decile groups reduced significantly for complications (12.77% vs 12.11%, OR=1.06 P =0.04), the differences in mortality rates collapsed, and differences in readmission rates remained insignificant.

Conclusions: These data suggest that Medicare beneficiaries who live in communities with lower social capital are more likely to undergo unplanned surgery for access-sensitive conditions. Efforts to improve social capital in these communities may be one strategy for reducing the rate of unplanned operations.

摘要背景:比较居住在不同社会资本水平人口普查区的受益人因对就医敏感的外科疾病而接受非计划手术的比例:背景:对就医敏感的外科病症是指在择期就医的情况下进行筛查和治疗的理想病症。然而,如果不加以治疗,这些病症可能会导致计划外(即紧急或急诊)手术。社会资本--个人通过加入社会网络而获得的资源--可能会影响计划内手术发生的可能性:根据人口普查区的社会资本水平(即暴露变量),对在 2016-2020 年间接受了三种敏感手术(腹主动脉瘤修补术、癌症结肠切除术和腹股沟疝修补术)之一的医疗保险受益人进行分层。研究结果包括非计划手术率、再入院率、30 天死亡率和并发症,这些指标均通过逻辑回归模型进行风险调整,该模型考虑了患者的年龄、性别、种族、合并症和地区贫困程度:共纳入 975 048 名受益人(平均 [SD] 患者年龄为 76 [7.6] 岁;443 190 人为男性 [45.45%])。与来自整体社会资本最高十分位数人口普查区的患者相比,来自社会资本最低人口普查区的患者平均更有可能接受计划外手术(40.67% 对 35.28%,OR=1.26):这些数据表明,生活在社会资本较低社区的医疗保险受益人更有可能因对就医敏感的疾病而接受计划外手术。努力改善这些社区的社会资本可能是降低意外手术率的策略之一。
{"title":"Social Capital and Surgery Access Among Medicare Beneficiaries.","authors":"Hannah E W Myers, Nicholas Kunnath, Andrew M Ibrahim","doi":"10.1097/SLA.0000000000006482","DOIUrl":"10.1097/SLA.0000000000006482","url":null,"abstract":"<p><strong>Objective: </strong>To compare the rates of unplanned procedures for access-sensitive surgical conditions among beneficiaries living in census tracts of varying social capital levels.</p><p><strong>Background: </strong>Access-sensitive surgical conditions are conditions ideally screened for and treated in an elective setting. However, when left untreated, these conditions may result in unplanned (ie, urgent or emergent) surgery. It is possible that social capital-the resources available to individuals through their membership in a social network-may impact the likelihood of a planned procedure occurring.</p><p><strong>Methods: </strong>Medicare beneficiaries who underwent 1 of 3 access-sensitive procedures (abdominal aortic aneurysm repair, colectomy for cancer, and ventral hernia repair) between 2016 and 2020 were stratified by their census tract level of social capital, the exposure variable. Outcomes included rate of unplanned surgery, readmission, 30-day mortality, and complications which were risk-adjusted with a logistic regression model that accounted for patient age, sex, race, comorbidities, and area deprivation.</p><p><strong>Results: </strong>A total of 975,048 beneficiaries were included [mean (SD) patient age, 76 (7.6) years; 443,190 were male (45.45%)]. Compared with patients from census tracts in the highest overall social capital decile, those from census tracts with the least social capital were, on average, more likely to undergo unplanned surgery [40.67% vs 35.28%, odds ratio (OR)=1.26 P <0.001]. In addition, beneficiaries in these communities were also more likely to experience postoperative complications (24.99% vs 22.90%, OR=1.12 P <0.001), but there was no significant difference in rates of readmission or mortality. When evaluating only elective procedures, the differences between the lowest and highest social capital decile groups reduced significantly for complications (12.77% vs 12.11%, OR=1.06 P =0.04), the differences in mortality rates collapsed, and differences in readmission rates remained insignificant.</p><p><strong>Conclusions: </strong>These data suggest that Medicare beneficiaries who live in communities with lower social capital are more likely to undergo unplanned surgery for access-sensitive conditions. Efforts to improve social capital in these communities may be one strategy for reducing the rate of unplanned operations.</p>","PeriodicalId":8017,"journal":{"name":"Annals of surgery","volume":" ","pages":"443-450"},"PeriodicalIF":6.4,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141974942","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Annals of surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1